Alto Pharmacy Stock

alto.comHealthcare / Digital HealthFounded: 2015Funding to Date: $656.12MM

Alto Pharmacy is a digital pharmacy focused on delivering prescriptions to patients without delivery fees. As with physical pharmacies, patients are able to chat directly with Alto pharmacists to ask questions about their care across general health, sexual health, heart health, fertility, and more. Alto Pharmacy was founded in 2015 by Jamie Karraker, Mattieu Gamache-Asselin, and Vladimir Blumen and is headquartered in San Francisco, CA.

Register To Buy and Sell Shares

For more details on private stock price information, financing and valuation for Alto Pharmacy, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Alto Pharmacy’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Alto Pharmacy.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Alicia Davis
Chief Executive Officer
Nihar Bhatt
Chief Financial Officer
Mike McClay
Chief Technology Officer

Board Members

John Westcott
SoftBank Investment Advisers
Neil Shah
Greenoaks Capital Partners
Nichola Eliovits
Olive Tree Capital

Alto Pharmacy’s stock FAQs


Can you buy Alto Pharmacy’s stock?

As Alto Pharmacy is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Alto Pharmacy, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge's Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Alto Pharmacy’s stock?

To invest in a private company like Alto Pharmacy’s through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)
  1. Create a free account to access Forge's marketplace.
  2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
  3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Alto Pharmacy’s stock?

Yes, you may be able to sell your Alto Pharmacy’s stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Alto Pharmacy’s stock?

If you hold private company shares of Alto Pharmacy’s - whether as an employee or an early investor - Forge can help you sell them.
  1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
  2. Indicate your interest to sell your Alto Pharmacy’s on our platform.
  3. Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Alto Pharmacy’s a public company?

No, Alto Pharmacy’s is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Alto Pharmacy’s stock price?

Alto Pharmacy is a privately held company and therefore does not have a public stock price. However, you may access Alto Pharmacy’s private market stock price with Forge Data.

What is Alto Pharmacy’s stock ticker symbol?

Alto Pharmacy does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

Mark Cuban Cost Plus Drug Company partners with Alto Pharmacy

Mark Cuban's Cost Plus Drug Company partners with Alto Pharmacy to provide low-cost prescription delivery to Team Cuban Card holders.

This Former Auto Executive Is Now CEO of a Billion-Dollar Online Pharmacy

Alicia Boler Davis was the most senior Black executive in the auto industry before joining Amazon, and later, Alto Pharmacy. Her mentors, she says, have pushed her to continually raise the bar for herself.

A Softbank-backed pharmacy startup is working to tackle a $300-billion-a-year prescription drug crisis

For years, the $500 billion prescription drug industry has loomed as an enticing target for disruption-minded entrepreneurs and corporations alike.

On track to hit $1B in revenue this year, Alto Pharmacy tapped an Amazon exec to lead its next phase of growth

Jamie Karraker and Mattieu Gamache-Asselin, who both previously worked at Facebook, bought an independent "mom-and-pop" pharmacy in San Francisco's Mission District to learn the workflows and pain points for consumers, doctors and pharmacists.
Updated on: Jul 25, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.